These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 25867026)

  • 21. Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma.
    Milano V; Piao Y; LaFortune T; de Groot J
    Mol Cancer Ther; 2009 Feb; 8(2):394-406. PubMed ID: 19190119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
    Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
    BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ER stress in temozolomide-treated glioblastomas interferes with DNA repair and induces apoptosis.
    Weatherbee JL; Kraus JL; Ross AH
    Oncotarget; 2016 Jul; 7(28):43820-43834. PubMed ID: 27286262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
    Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
    Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line.
    Josset E; Burckel H; Noël G; Bischoff P
    Anticancer Res; 2013 May; 33(5):1845-51. PubMed ID: 23645729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells.
    Scotland S; Saland E; Skuli N; de Toni F; Boutzen H; Micklow E; Sénégas I; Peyraud R; Peyriga L; Théodoro F; Dumon E; Martineau Y; Danet-Desnoyers G; Bono F; Rocher C; Levade T; Manenti S; Junot C; Portais JC; Alet N; Récher C; Selak MA; Carroll M; Sarry JE
    Leukemia; 2013 Nov; 27(11):2129-38. PubMed ID: 23568147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo.
    Momota H; Nerio E; Holland EC
    Cancer Res; 2005 Aug; 65(16):7429-35. PubMed ID: 16103096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.
    Benedetti E; Antonosante A; d'Angelo M; Cristiano L; Galzio R; Destouches D; Florio TM; Dhez AC; Astarita C; Cinque B; Fidoamore A; Rosati F; Cifone MG; Ippoliti R; Giordano A; Courty J; Cimini A
    Oncotarget; 2015 Dec; 6(39):42091-104. PubMed ID: 26540346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors.
    Panosyan EH; Wang Y; Xia P; Lee WN; Pak Y; Laks DR; Lin HJ; Moore TB; Cloughesy TF; Kornblum HI; Lasky JL
    Mol Cancer Res; 2014 May; 12(5):694-702. PubMed ID: 24505127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
    Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
    Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The sodium pump could constitute a new target to combat glioblastomas].
    Lefranc F; Mijatovic T; Kiss R
    Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments.
    Palumbo S; Pirtoli L; Tini P; Cevenini G; Calderaro F; Toscano M; Miracco C; Comincini S
    J Cell Biochem; 2012 Jul; 113(7):2308-18. PubMed ID: 22345070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A).
    Choi J; Lee JH; Koh I; Shim JK; Park J; Jeon JY; Yun M; Kim SH; Yook JI; Kim EH; Chang JH; Kim SH; Huh YM; Lee SJ; Pollak M; Kim P; Kang SG; Cheong JH
    Oncotarget; 2016 Oct; 7(40):65643-65659. PubMed ID: 27582539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
    Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
    Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
    Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
    Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms.
    Chakravarti A; Erkkinen MG; Nestler U; Stupp R; Mehta M; Aldape K; Gilbert MR; Black PM; Loeffler JS
    Clin Cancer Res; 2006 Aug; 12(15):4738-46. PubMed ID: 16899625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F; Rynkowski M; DeWitte O; Kiss R
    Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo.
    Ziegler DS; Keating J; Kesari S; Fast EM; Zawel L; Ramakrishna N; Barnes J; Kieran MW; Veldhuijzen van Zanten SE; Kung AL
    Neuro Oncol; 2011 Aug; 13(8):820-9. PubMed ID: 21724651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.
    Jaime-Ramirez AC; Dmitrieva N; Yoo JY; Banasavadi-Siddegowda Y; Zhang J; Relation T; Bolyard C; Wojton J; Kaur B
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28087981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.